For each citation that was shared on social media (LinkedIn, Facebook, or Twitter) with the “@GenScript” tag, the author will be rewarded with a $10 Amazon gift card or 2,000 GS points.

Small Peptide Modulation of Fibroblast Growth Factor Receptor 3-Dependent Postnatal Lymphangiogenesis.

Lymphat Res Biol. 2019; 
PerraultDavid P,LeeGene K,ParkSun Young,LeeSunju,ChoiDongwon,JungEunson,SeongYoung Jin,ParkEun Kyung,SungCynthia,YuRoy,BouzAntoun,PourmoussaAustin,KimSoo Jung,HongYoung-Kwon,WongAl
Products/Services Used Details Operation
Peptide Synthesis … Sources or other reagents used are as follows: 9-cisRA (R4643; Sigma-Aldrich, Inc.) and FGF2 (Sigma). Peptide P3 (VSPPLTLGQLLS) and scrambled peptide (LQVLSTLPSLGP) were synthesized in vitro with guaranteed TFA removal and at a purity >98% (GenScript USA, Inc.) … Get A Quote

Abstract

The fibroblast growth factor receptor (FGFR) family includes transmembrane receptors involved in a wide range of developmental and postdevelopmental biologic processes as well as a wide range of human diseases. In particular, FGFR3 has been implicated in the mechanism by which 9-cis retinoic acid (9-cisRA) induces lymphangiogenesis and improves lymphedema. The purpose of this study was to validate the efficacy of a novel small peptide FGFR3 inhibitor, peptide P3 (VSPPLTLGQLLS), and to elucidate the role of FGFR3 in 9-cisRA-induced lymphangiogenesis using this peptide.

Keywords

9-cis retinoic acid,FGFR3,VSPPLTLGQLLS,lymphangiogenesis,lymphatic endothelial cell,lymphedema,peptide inhib